 - Patients with MM in the Plateau Phase of their disease may be included in the study. Plateau phase will be defined as persistent more than 6 weeks M-protein in the serum or urine despite a significant initial reduction 50 in response to previous therapy. These patients should have received at least two of the conventional chemotherapy regimens listed above prior to enrollment in this study. 